Showing results (51-60 of 4,006) with videos related to
Sort By:
Pageof 401
Biochemical Pharmacology|June 1, 1997
Interactions of amphetamine analogs with human liver CYP2D6D Wu, S V Otton, T Inaba, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Oxazepam as a probe of hepatic metabolism in patients with Alzheimer's diseaseM Fisman, T Inaba, W Kalow, et al.Canadian Journal of Physiology and Pharmacology|July 1, 1984
A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenaseT Inaba, M Nakano, S V Otton, et al.Journal of Chromatography|March 8, 1991
Simultaneous quantitation of loxapine, amoxapine and their 7- and 8-hydroxy metabolites in plasma by high-performance liquid chromatographyS W Cheung, S W Tang, G RemingtonPsychiatry and Clinical Neurosciences|February 25, 2000
Cultural difference in recognition of facial emotional expression: contrast between Japanese and American ratersT Shioiri, T Someya, D Helmeste, et al.Psychiatry and Clinical Neurosciences|April 14, 1999
Misinterpretation of facial expression: a cross-cultural studyT Shioiri, T Someya, D Helmeste, et al.Pharmacology & Toxicology|July 1, 1990
Sparteine metabolism capacity in human liver: structural variants of human P450IID6 as assessed by immunochemistryR F Tyndale, F J Gonzalez, J P Hardwick, et al.Psychiatry and Clinical Neurosciences|January 23, 1999
Frequency distribution of serum cholesterol levels in patients with panic disorder: comparison with normal controlsT Shioiri, K Fujii, T Someya, et al.Acta Psychiatrica Scandinavica|February 1, 1996
The symptom structure of panic disorder: a trial using factor and cluster analysisT Shioiri, T Someya, J Murashita, et al.Journal of Affective Disorders|April 27, 2000
Serum cholesterol levels and panic symptoms in patients with panic disorder: a preliminary studyT Shioiri, K Fujii, T Someya, et al.Pageof 401